32640-96-3 Usage
Uses
Used in Pharmaceutical Industry:
4,4,6-triMethyl-1,2,3,4-tetrahydroquinoline serves as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 4,4,6-triMethyl-1,2,3,4-tetrahydroquinoline is employed as a precursor for the production of various agrochemicals, including pesticides and herbicides. Its structural properties enable the creation of effective compounds for crop protection and management.
Used in Organic Synthesis:
4,4,6-triMethyl-1,2,3,4-tetrahydroquinoline is utilized as a versatile building block in organic synthesis, allowing for the creation of a wide range of chemical compounds. Its reactivity and structural features make it suitable for use in the synthesis of various organic molecules for different applications.
Used in Research and Development:
Due to its unique structure and potential applications, 4,4,6-triMethyl-1,2,3,4-tetrahydroquinoline is a valuable compound in research and development. It is used to explore new chemical reactions, investigate its properties, and develop innovative applications in various fields, including materials science and chemical engineering.
Check Digit Verification of cas no
The CAS Registry Mumber 32640-96-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,6,4 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 32640-96:
(7*3)+(6*2)+(5*6)+(4*4)+(3*0)+(2*9)+(1*6)=103
103 % 10 = 3
So 32640-96-3 is a valid CAS Registry Number.
32640-96-3Relevant academic research and scientific papers
COMPOUNDS AND METHODS FOR INHIBITION OF RENIN, AND INDICATIONS THEREFOR
-
Page/Page column 86, (2010/11/18)
Compounds active as inhibitors of renin are described, as well as methods of using such compounds to treat diseases and conditions associated with the renin-angiotensin system. Formula (I)
